The portal profiles more than 50 labs and research groups in the San Francisco Bay Area -- including academic labs and programs led by scientists in industry, government agencies, and private research institutes. The portal can serve as a tool for cooperation and exchange within our local research community. Browse the profiles of affiliated labs to identify partnership opportunities, facilities, and resources offered by Bay Area researchers.

To add your lab to the portal, visit

Investigator Affiliation Interests Keywords
Peter A. Barry UC Davis Mechanisms of cytomegalovirus (CMV) persistence and pathogenesis; Nonhuman primate models of human CMV; Modeling of human CMV vaccine strategies in a nonhuman primate model
Paul A. Luciw UC Davis Viral Pathogenesis and Therapy (HIV and AIDS) Biomarkers for Infectious Diseases and Cancer Retroviruses, Persistent Infection, Nonhuman Primate Models, HIV and AIDS
Raul Andino UCSF RNA virus replication, virus population dynamics and evolution RNA virus, virus detection by host, RNAi, antiviral response.
Jody Baron UCSF Innate and adaptive immunity to viral pathogens. Immune response, Hepatitis B
Nichole Baumgarth UC Davis We are interested in understanding the regulation of immunity to influenza virus with particular emphasis on the regulation of the local B cell responses by innate signals and the B cell subsets that are contributing to immune defense against respirator Immune regulation; antiviral immunity; humoral immunity; respiratory tract immunity; B cell subset responses; B-1 cells; natural antibodies
Monica Borucki Lawrence Livermore National Lab evolution, quasispecies, forensics evolution, quasispecies, forensics
Gertrude Buehring UC Berkeley My area of research is oncogenic viruses--viruses that cause human cancer. molecular epidemiology, oncogenic viruses and human cancers
Jan Carette Stanford Research focuses on identification of host genes using haploid genetic screens in human cells; obtain fundamental insights on how viruses hijack cellular processes and on host defense mechanisms; facilitate the development of new therapeutic strategies. virology, immunology, genetics, influenza
Charles Chiu UCSF Metagenomics-Based Technologies for Virus Detection and Discovery Viral Detection and Discovery, Clinical Diagnostics, Pathogen Detection Microarrays, Deep Sequencing, Metagenomics
Jinah Choi UC Merced HCV, oxidative stress, mutation, interferon
Candice Clay California National Primate Research Center Our lab has largely focused on understanding the development of asthma, exploring the relationship between childhood asthma and exposure to allergens and environmental air pollution. Respiratory syncytial virus, Rhinovirus, influenza, Tobacco, side stream cigarette smoke, asthma
Laurent Coscoy UC Berkeley herpesvirus, innate immune response
Charles Craik UCSF The Craik lab focuses on viral proteases with a current emphasis on HIV and the human herpesviruses. Specifically, we are interested in host-virus interactions involving proteases as well as small molecules and biologics for the modulation of protease act small-molecule allosteric inhibition, protein-protein interaction, host-virus interaction, restriction factor identification, structure-function characterization, proteases
Joseph DeRisi UCSF Genomics, proteomics, informatics, etc. Viral discovery, RNA viruses, metagenomics, viral-host interactions, viral recombination
Jerome Deval Alios BioPharma Alios is a biotechnology company located in South San Francisco, California, that is developing novel medicines to treat viral diseases. Alios has two platform technologies: novel nucleoside/nucleotide chemistries and small molecule activators of the RN Antivirals, RNA polymerases, drug discovery, HCV, Influenza virus, RSV, nucleoside, RNase L
James E.K. Hildreth UC Davis My laboratory research is focused on understanding mechanisms by which HIV subverts host pathways and molecules during its replication cycle. We are particularly interested in the role of cholesterol and cholesterol homeostatic pathways in virus entry, vi HIV-1, cholesterol, HIV-1 and co-infecting viruses
Shirit Einav Stanford Focuses on better understanding interactions of Flaviviridae with the human host and their inhibition. Flaviviridae, viral-host protein-protein interactions, antivirals, assembly, budding
Bryce Falk UC Davis Work with plant viruses; their biology and molecular biology, and engineering plants for resistance against virus infections.
Margaret Feeney UCSF Immunopathogenesis of HIV and malaria in childhood Immunopathogenesis, HIV, malaria, T-cell response, immune response
Ellen Fiss Roche Molecular Systems Diagnostic assays for the detection of viruses. diagnostic, assay, detection
Alan Frankel UCSF Assembly and evolution of RNA-protein complexes and virus-host interactions. HIV – Tat and Rev proteins: their biochemistry, structure and interactions. RNA-protein, HIV, Tat protein, Rev protein, virus-host interaction
Britt Glaunsinger UC Berkeley Studying how viruses interface with host gene expression machinery; emphasis on gammaherpesviruses. herpesvirus, RNA turnover, host shutoff
Harry Greenberg Stanford Long-standing interests in rotavirus, influenza, hepatitis B and C and Noroviruses. Interests in viral immunity (innate and acquired), pathogenesis and vaccines Rotavirus, influenza, hepatitis B and C, notaviruses, viral immunity, pathogensis, vaccines
John Gross UCSF The control of eukaryotic gene expression at the level of mRNA metabolism. Biology of HIV-host complexes. gene expression, mRNA metabolism, HIV-host
Eva Harris UC Berkeley Correlate of protection of vaccines, cross-reactive B cell response
Laura Hertel CHORI, Center for Immunobiology and Vaccine Development Mechanisms regulating human cytomegalovirus (CMV) tropism and latency, in particular, how CMV gains access to specific cells of the innate immune system, the dendritic cells, and how the CMV genome is maintained within the host bone marrow cells for life. Human Cytomegalovirus, CMV, tropism, latency, vaccine, innate immune system
Christopher J. Miller UC Davis Center for Comparative Medicine My laboratory utilizes non-human primate models of AIDS and influenza A virus infection to define the pathogenesis of these viral infections, study the nature of protective antiviral immunity, and test vaccines and immunotherapeutic strategies to preven Viral Pathogenesis Anti-viral Immunity Mucosal Immunology RNA viruses
Hong Jin MedImmune Negative strand RNA viruses
Nevan Krogan UCSF High-troughput analysis of host-pathogen interactions in HIV, enteroviruses, dengue virus host-pathogen interaction, HIV, enterovirus, dengue virus
Desiree LaBeaud CHORI Explore the risk factors of arthropod-borne viral diseases (Rift Valley fever (RVFV), dengue (DENV) and chikungunya (CHIKV) viruses) to understand transmission, optimize prevention and control, and estimate the proportion of acute febrile illness. anthropod-borne viral diseases, Rift Valley fever, RVFV, dengue, DENV, chikungunya, CHIKV, transmission, epidemiology, diagnostics
Jennifer Lavail UCSF Axonal Transport Mechanisms of Herpes Simplex Virus in CNS Neurons axonal transport, herpes simplex virus, CNS neurons
Jay Levy UCSF Research in our laboratory deals with virologic, immunologic and molecular studies of HIV pathogenesis and vaccine development. Specific attention is given to the innate immune response against HIV including that of dendritic cells and CD8+ lymph Innate immunity, HIV, non-cytotoxic CD8+ cell antiviral activity, HIV vaccine development
Zengji Li BN ImmunoTherapeutics Poxvirus vector cancer vaccine
Uri Lopatin Assembly Pharmaceuticals HBV, drug development, immunology, allostery
Susan Lynch UCSF Human microbiome,including its perturbations in HIV patients. Chronic inflammatory disease. human microbiome, HIV, chornic inflammatory disease
Stephanie Mandl BN ImmunoTherapeutics BN ImmunoTherapeutics is a biotech company that is developing poxvirus based immunotherapies for cancer. Tumor immunology, breaking tolerance, vaccine development, immunotherapy
B. Matija Peterlin UCSF Study the molecular biology of HIV and endogenous retroviruses with special emphasis on transcription, restriction and proviral latency; focus is on Tat:P-TEFb, Nef, Vif:APOBEC, and aspects of other accessory proteins. Transcription, latency, reservoir, restriction, integration, silencing, replication
Mehrdad Matloubian UCSF Lymphocyte migration and autoimmune disease as revealed by the lymphocytic choreomeningitis virus lymphocyte migration, autoimmune disease, lymphocytic choreomeningitis virus
Alison McCormick Touro University, California Vaccines, Virology, Public Health
Mike McCune UCSF Pathogenic Mechanisms, Treatment, and Prevention of HIV Disease pathogenic mechanisms, treatment, prevention, HIV
Mohammad Mofrad UC Berkeley (Bioengineering) Using computational models to shed light on the process by which HIV Rev oligomerizes on the Rev Response Element (RRE) sequence of the viral genome and recruits crm1 (chromosome region maintenance 1; also referred to as exportin1) to export this genome. HIV, HIV replication, viral genome, bioengineering.
Brian Murphy UC Davis Interested in retroviral promoter function/regulation and how it relates to viral pathogenesis (FIV, SIV, CAEV, ENTV, JSRV). transcriptional regulation and latency- host:viral cross-regulation
Doug Nixon UCSF Cellular immune responses to HIV cellular immune responses, HIV, immunity
Philip Norris Blood Systems Research Institute Understanding the role CD4+T helper cells play in the body's immune defense against viral infections, such as HIV. Understanding acute immune response to West Nile virus and other flavivirus infection. Defining the types and mechanisms of immune reactio T-cell immunology, cytokine networks, human viral pathogenesis
Patricia Pesavento School of Vetrinary Medicine, UC Davis We divide our research time between enigmatic cases of disease in group-housed (shelter) animals, and a basic research program on host:viral pathogen interactions. What unites all of our work is our desire to study natural disease and to help make sense, virus, pathology, oncogenesis
Daniel Portnoy UC Berkeley Pathogen immune evasion, pathogenesis Immune evasion, pathogenesis
Mary Premenko-Lanier UCSF Cellular immune dysfunction during persistent viral infections cellular immune dysfunction, viral infection, immunity
David Raulet UC Berkeley We are interested in how natural killer cells recognize virus-infected cells. A specific focus concerns how viral infections induce expression in infected cells of cell surface ligands recognized by NK cell activating receptors, such as NKG2D. Immune activation, innate immunity
Peter Sarnow Stanford Virus-host interactions, cellular and viral translation, miRNA regulation of gene expression
David Schaffer UC Berkeley Stem Cells, Gene therapy and HIV gene therapy, RNA viruses, HIV-1, viral latency
Barbara Shacklett UC Davis Mucosal immunity to HIV and SIV (gastrointestinal and reproductive mucosa). Trafficking of antigen-specific T-cells to mucosal tissues and the central nervous system. Natural Killer cells and non-classical effector cells in mucosal tissues. Mucosal immunity Cytotoxic T-cells Host Responses Adaptive immunity
Mina Sun UC Berkeley Virus DNA packaging mechanisms virus, DNA, virology
Jane Sykes UC Davis Viral infections of dogs and cats Clinical virology
Julian Symons Alios BioPharma Inc. Alios BioPharma is a biotechnology company located in South San Francisco, California, that is developing novel medicines aimed at the treatment of viral diseases. Alios is developing direct acting antiviral agents against several human viral pathogens of Chronic hepatitis C, hepatotropic viruses, respiratory viruses, RNase L, direct acting antiviral agents.
Russell Vance UC Berkeley Innate immunity, host-pathogen biology, inflammasome activation
Jonatahn Weissman UCSF Global monitoring of protein translation and mRNA transcription, including in viral systems protein translation, mRNA transcription, viral systems
JoAnn Yee UC Davis Infectious Disease in Animal Models Infectious Disease in Nonhuman primates.